Zheng Zhi, Bu Fan-Di, Chen Hao, Yin Jie, Xu Rui, Cai Jun, Zhang Jun, Yao Hong-Wei, Zhang Zhong-Tao
Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center for Digestive Diseases, Beijing 100050, China.
Department of Pathology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.
World J Clin Cases. 2021 Apr 6;9(10):2192-2204. doi: 10.12998/wjcc.v9.i10.2192.
Controversy exists about the benefit of additional surgery after endoscopic submucosal dissection (ESD) for early gastric cancer (EGC).
To examine risk factors for overall survival (OS) after additional surgery in patients with EGC who initially underwent ESD.
This was a retrospective analysis of patients with EGC who underwent additional surgery after ESD at the Beijing Friendship Hospital affiliated to Capital Medical University between August 2012 and August 2019. OS was the primary outcome. Lymph node metastasis and residual tumor were secondary outcomes. Logistic regression models and Kaplan-Meier curves were used for further analysis.
Forty-two patients were evaluated, including 35 (83.3%) males and 7(16.7%) females. The mean age was 62 (range, 32-82) years. Male sex [hazard ratio (HR) = 21.906, 95% confidence interval (CI): 3.762-229.250; = 0.039), T1b invasion (HR = 3.965, 95%CI: 1.109-17.432; = 0.047), undifferentiated tumor (HR = 9.455, 95%CI: 0.946-29.482; = 0.049), lymph node metastasis (HR = 2.126, 95%CI: 0.002-13.266; = 0.031), and residual tumor (HR = 4.275, 95%CI: 1.049-27.420; = 0.043) were independently associated with OS. The follow-up duration was 4-81 mo (median: 50.7 mo). OS was 77.0 ± 12.1 mo (95%CI: 53.3-100.7 mo). The 3-year and 5-year OS rates were 94.1% and 85%, respectively.
Male sex, T1b invasion, undifferentiated tumor, lymph node metastasis, and residual tumor are independently associated with OS in patients with EGC who underwent additional surgery after ESD.
对于早期胃癌(EGC)内镜黏膜下剥离术(ESD)后额外手术的益处存在争议。
研究最初接受ESD的EGC患者额外手术后总生存(OS)的危险因素。
这是一项对2012年8月至2019年8月在首都医科大学附属北京友谊医院接受ESD后又接受额外手术的EGC患者的回顾性分析。OS是主要结局。淋巴结转移和残留肿瘤是次要结局。使用逻辑回归模型和Kaplan-Meier曲线进行进一步分析。
共评估了42例患者,其中男性35例(83.3%),女性7例(16.7%)。平均年龄为62岁(范围32 - 82岁)。男性[风险比(HR)= 21.906,95%置信区间(CI):3.762 - 229.250;P = 0.039]、T1b浸润(HR = 3.965,95%CI:1.109 - 17.432;P = 0.047)、未分化肿瘤(HR = 9.455,95%CI:0.946 - 29.482;P = 0.049)、淋巴结转移(HR = 2.126,95%CI:0.002 - 13.266;P = 0.031)和残留肿瘤(HR = 4.275,95%CI:1.049 - 27.420;P = 0.043)与OS独立相关。随访时间为4 - 81个月(中位数:50.7个月)。OS为77.0 ± 12.1个月(95%CI:53.3 - 100.7个月)。3年和5年总生存率分别为94.1%和85%。
男性、T1b浸润、未分化肿瘤、淋巴结转移和残留肿瘤与ESD后接受额外手术的EGC患者的OS独立相关。